Sydney, May 13, 2026, 05:10 AEST
- PLS finished Tuesday’s session at A$6.50, a gain of 3.5%. The stock hit A$6.59 at its peak, with 32.14 million shares changing hands—well ahead of its recent average.
- Commodities were in the driver’s seat here. Chinese lithium carbonate futures climbed 1.7% to 205,680 yuan a tonne, while names like Liontown and IGO followed suit with gains.
- Bulls are betting on operating leverage if lithium prices keep climbing. The bears? They’re calling it a crowded, jumpy trade—especially after PLS’s sharp run-up from last year’s low.
PLS Group Limited, which trades on the ASX and was previously Pilbara Minerals, finished Tuesday’s session at A$6.50—22 cents higher. Shares touched A$6.59 intraday, matching their 52-week high per Google Finance data, before slipping back by the close. The ASX has closed at the dateline; these figures reflect the most recent cash-session.
The answer jumped out on the commodities screen. Chinese lithium carbonate futures gained 1.7% early, hitting 205,680 yuan a tonne. That puts prices up roughly 9% over five weeks, the highest since August 2023. For PLS, this is key. Their main product? Spodumene concentrate — crushed rock loaded with lithium, which gets turned into battery chemicals.
Lithium names jumped across the board, not just one outlier. Liontown picked up 6.3%, IGO climbed 5.0% in early afternoon, Mineral Resources joined the move. Core Lithium trailed, a sign that the rally wasn’t indiscriminate—investors weighed size and balance sheet.
PLS stands out among local players for its exposure to lithium prices. The company’s Pilgangoora site in Western Australia—fully owned, and touted by PLS as the world’s largest independent hard-rock lithium operation—accounts for roughly 8% of global lithium supply. Production capacity could hit 1 million tonnes of spodumene concentrate annually once the P1000 expansion is complete.
The latest company announcement landed as little more than register chatter rather than substantial news on output. Morgan Stanley and MUFG have shown up in recent substantial-holder filings—those go to investors holding at least a 5% voting stake. That’s likely fueling the spotlight on the stock. Still, it leaves tonnes, costs, and realized pricing untouched.
Bulls have their case. In its March-quarter update, PLS posted record spodumene concentrate output—232,436 dry metric tons, or dmt, which leaves out water weight. According to Reuters, that’s an 86% jump from the year before. Unit operating costs? Down 11% from the previous quarter to A$520 per metric ton. The company is sticking with its FY2026 output target, holding the range at 820,000 to 870,000 tonnes.
RBC Capital’s Kaan Peker described the quarter as “a clear beat,” pointing to better-than-expected production numbers and costs coming in lower. CEO Dale Henderson, in comments to Reuters, noted “deepening and broadening demand” for lithium, from stationary batteries to electric trucks. Reuters
Bears push back hard: PLS still has to take whatever price the market gives it, with revenue tied to prevailing rates, not something it sets. And there’s more—according to that same Reuters report, unit costs are likely heading up this quarter, thanks to expenses tied to restarting Ngungaju. Not a small issue, considering the stock’s already rallied from its A$1.14 low on June 3, 2025, all the way to A$6.50.
Management’s message has stayed cautious. PLS has signed off on restarting the Ngungaju plant, which can turn out about 200,000 tonnes a year, aiming for production to kick off again in July 2026. Henderson described the move as part of a “through-the-cycle strategy” after the slump. As for the P2000 feasibility study—meant to push Pilgangoora’s capacity up to around 2.0 million tonnes annually—it’s still on track for the December quarter of 2026, though it’s waiting on a final investment decision. PLS
The share-price action isn’t just about sentiment—there’s a capital structure angle too. In April, PLS wrapped up a US$600 million senior unsecured notes deal at 6.875% due 2031. Part of those funds went to pay down a drawn revolving credit facility, which was then halved from A$1 billion to A$500 million. On paper, that frees up some room. But now there’s a locked-in debt cost sitting in the accounts, just as the market is pricing in growth optionality.
The mid-stream project’s another wrinkle. PLS has kicked off commissioning on a demonstration plant, lined up as much as A$38.1 million in grant money from ARENA, and inked an offtake agreement with Ronbay for lithium phosphate. Henderson described this as a “disciplined validation and optimisation phase” — accurate enough, since what they’ve got is optionality, not evidence of a fatter-margin business just yet. PLS
Tuesday’s jump made sense, but hardly screamed safety. Lithium prices jolted investors into rethinking PLS’s idle capacity, scale, and downstream plays—everything got repriced in one shot. The risk? It’s right there: with shares racing this far from last year’s lows, the commodity price needs to keep carrying the load.
